ATE374040T1 - Nukleoprotein des toscanavirus - Google Patents

Nukleoprotein des toscanavirus

Info

Publication number
ATE374040T1
ATE374040T1 AT00987600T AT00987600T ATE374040T1 AT E374040 T1 ATE374040 T1 AT E374040T1 AT 00987600 T AT00987600 T AT 00987600T AT 00987600 T AT00987600 T AT 00987600T AT E374040 T1 ATE374040 T1 AT E374040T1
Authority
AT
Austria
Prior art keywords
nucleoprotein
toscana virus
virus
toscana
antigen
Prior art date
Application number
AT00987600T
Other languages
English (en)
Inventor
Maria Cusi
Marcello Valassina
Pier Valensin
Original Assignee
Univ Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Siena filed Critical Univ Siena
Application granted granted Critical
Publication of ATE374040T1 publication Critical patent/ATE374040T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00987600T 1999-12-16 2000-12-18 Nukleoprotein des toscanavirus ATE374040T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9929783.0A GB9929783D0 (en) 1999-12-16 1999-12-16 Toscana virus nucleoprotein

Publications (1)

Publication Number Publication Date
ATE374040T1 true ATE374040T1 (de) 2007-10-15

Family

ID=10866464

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00987600T ATE374040T1 (de) 1999-12-16 2000-12-18 Nukleoprotein des toscanavirus

Country Status (10)

Country Link
EP (1) EP1237571B1 (de)
AT (1) ATE374040T1 (de)
AU (1) AU2390101A (de)
CY (1) CY1107607T1 (de)
DE (1) DE60036563T2 (de)
DK (1) DK1237571T3 (de)
ES (1) ES2293934T3 (de)
GB (1) GB9929783D0 (de)
PT (1) PT1237571E (de)
WO (1) WO2001044288A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298423A (en) * 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins
ITMI980889A1 (it) * 1998-04-24 1999-10-24 Diesse Diagnostica Nucleoproteina ricombinante del virus toscana

Also Published As

Publication number Publication date
WO2001044288A2 (en) 2001-06-21
PT1237571E (pt) 2007-12-31
DK1237571T3 (da) 2008-01-02
DE60036563D1 (de) 2007-11-08
GB9929783D0 (en) 2000-02-09
WO2001044288A3 (en) 2002-01-24
DE60036563T2 (de) 2008-07-17
CY1107607T1 (el) 2013-03-13
ES2293934T3 (es) 2008-04-01
EP1237571B1 (de) 2007-09-26
AU2390101A (en) 2001-06-25
EP1237571A2 (de) 2002-09-11

Similar Documents

Publication Publication Date Title
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
WO2009072767A3 (en) A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant
EA200801798A1 (ru) Виросомоподобные везикулы, содержащие антигены, производные от gp41
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
NO20070551L (no) Vaksinesammensetninger og fremgangsmater for behandling av koronavirus infeksjon.
ATE350057T1 (de) Impfstoffzusammesetzung
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
DE60039715D1 (de) Hcv-impfstoff zusammensetzungen
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
EP1305042A4 (de) Zusammensetzungen und methoden zur behandlung von schleimhautinfektionen
IL182440A0 (en) Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection
WO2004026260A3 (en) Prophylactic and therapeutic hiv aptamers
WO2022173714A3 (en) Antibodies that bind metapneumovirus, antigenic metapneumovirus proteins, and uses thereof
PL1949913T3 (pl) Immunostymulująca kombinacja do profilaktyki i leczenia wirusowego zapalenia wątroby typu c
ATE374040T1 (de) Nukleoprotein des toscanavirus
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
BR0111785A (pt) Composições e métodos para tratamento de candidìase
ATE378351T1 (de) Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
AR027738A1 (es) Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas
CY1107374T1 (el) Εμβολιο ιχθυος εναντι της piscirickettsia salmonis
WO2004064784A3 (en) Composition and method for preventing or treating a virus infection

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1237571

Country of ref document: EP